TRIALS IN TREATING STIs, VACCINES AND LIPID LOWERING MEDICATIONS
Dr Pi Lip Seet,
Principal Investigator
Paratus Clinical, Brisbane &
Surgical Registrar
Brisbane, Queensland, Australia
RESEARCHER PROFILE
Filmed in Brisbane | March 2026
Dr Pi Lip Seet graduated from the University of Queensland with a Bachelor of Medicine and Bachelor of Surgery, after completing a Bachelor of Biomedical Science at the University of Newcastle. He has undertaken broad hospital-based training across Queensland and the ACT, with clinical experience in Emergency Medicine, General and Orthopaedic Surgery, Plastic and Reconstructive Surgery, Intensive Care and Coronary Care.
Since joining Paratus Clinical Research in 2022, Dr Seet has served as both Principal Investigator and Sub-Investigator across Phase I–IV industry-sponsored clinical trials. His research experience spans vaccines, immunology, cardiovascular and endocrine disease, respiratory medicine, gastroenterology, pain management, sleep medicine and adult psychiatry. He has been involved in multiple vaccine development programs, including RSV, influenza, COVID-19, herpes zoster and pneumococcal studies.
Dr Seet maintains current Good Clinical Practice certification and advanced life support training. With a strong foundation in acute and procedural medicine, he is committed to delivering high-quality, ethical clinical research, ensuring participant safety while supporting the advancement of innovative therapeutic and vaccine programs.
Source: Supplied
-
Joanne Chio
ICON CANCER CENTRE – SINGAPORE
SINGAPORE -
Mechanisms of resistance to menin inhibitor therapy and Acute Myeloid Leukaemia
Dr Rithin Nedumannil (MBBS, MPH, FRACP, FRCPA) is a PhD candidate at the University of Melbourne, undertaking his doctoral studies in collaboration with the Cambridge Stem Cell Institute (Cambridge, UK) and the Peter MacCallum Cancer Centre (Melbourne, Australia). He is a clinical haematologist and haematopathologist with current appointments at Peter MacCallum Cancer Centre, the Royal Melbourne Hospital, Austin Health and Northern Health.
-
Next Generation Condom Contraception, Dr Simon Cook
Dr. Simon Cook, Co-Founder and Executive Director of Operations at Eudaemon Technologies, has had a diverse and impactful career journey. Beginning with a background in biotechnology from the University of Wollongong, his focus on bacterial pathogenesis during his PhD led him to study Group A Strep and the streptokinase protein.
Subsequently, Dr. Cook ventured into a unique project funded by the Bill and Melinda Gates Foundation, where he became involved in the development of a next-generation condom to address existing issues such as feel, odour, and taste.
